论文标题
通过测试政策对流行病进行建模和控制
Modeling and Control of Epidemics through Testing Policies
论文作者
论文摘要
当疫苗尚未可用时,测试是流行病开始阶段的关键控制机制。它使公共卫生当局能够检测并隔离受感染的病例,从而将疾病的传播限制在易感人群中。然而,尽管测试在流行病中具有重要意义,但有关该主题的最新文献缺乏控制理论的观点。在本文中,提出了一种流行病模型,该模型将测试率纳入了对照输入,并将未被发现的感染与被发现的受感染病例区分开来,这些病例被认为是从人群中疾病扩散过程中删除的。在与法国共同-19的开始阶段相对应的数据上估算了模型之后,提出了两个测试策略:所谓的最佳测试策略(最佳)和恒定的测试最佳策略(成本)。最好的政策是一种抑制策略,该策略提供了最低测试率,该策略在实施时阻止了流行病的增长。另一方面,成本政策是一种缓解策略,在测试的总库存有限时,可最大程度地降低感染人群的峰值的测试速率值。两种测试策略均通过对现有重症监护病房(ICU)案件的数量和法国案件的累积死亡人数的影响来评估。
Testing is a crucial control mechanism in the beginning phase of an epidemic when the vaccines are not yet available. It enables the public health authority to detect and isolate the infected cases from the population, thereby limiting the disease transmission to susceptible people. However, despite the significance of testing in epidemic control, the recent literature on the subject lacks a control-theoretic perspective. In this paper, an epidemic model is proposed that incorporates the testing rate as a control input and differentiates the undetected infected from the detected infected cases, who are assumed to be removed from the disease spreading process in the population. After estimating the model on the data corresponding to the beginning phase of COVID-19 in France, two testing policies are proposed: the so-called best-effort strategy for testing (BEST) and constant optimal strategy for testing (COST). The BEST policy is a suppression strategy that provides a minimum testing rate that stops the growth of the epidemic when implemented. The COST policy, on the other hand, is a mitigation strategy that provides an optimal value of testing rate minimizing the peak value of the infected population when the total stockpile of tests is limited. Both testing policies are evaluated by their impact on the number of active intensive care unit (ICU) cases and the cumulative number of deaths for the COVID-19 case of France.